Solid Biosciences Inc. — Director's Dealing 2024

Feb 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2024-02-13

Reporting Person: Herzich Paul (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-13	Employee Stock Option (Right to Buy)	$7.85	A	57500	Acquired	2034-02-13	Common Stock (57500)	Direct
2024-02-13	Restricted Stock Units	$	A	28750	Acquired		Common Stock (28750)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6022	Direct

Footnotes

F1: Includes 1,752 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023.

F2: This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.

F3: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F4: The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.